CVAC logo

CureVac N.V. (CVAC) EBITDA

annual EBITDA:

$226.96M+$483.08M(+188.61%)
December 31, 2024

Summary

  • As of today (September 8, 2025), CVAC annual EBITDA is $226.96 million, with the most recent change of +$483.08 million (+188.61%) on December 31, 2024.
  • During the last 3 years, CVAC annual EBITDA has risen by +$684.24 million (+149.63%).
  • CVAC annual EBITDA is now at all-time high.

Performance

1-year change

+188.61%

3-year change

+149.63%

5-year change

+321.56%

15-year change

+386.55%

CVAC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

88.79%
CVAC annual EBITDA is higher than 88.79% of companies in Healthcare sector

Range

All-time high

$226.96M
CVAC annual EBITDA is currently at an all-time high

3-year low

-$457.28M

Earnings dates

Last annual earnings report date

Dec 31, 2024
CVAC previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
CVAC next annual earnings announcement has not yet been scheduled

OtherCVACincome statement metrics

Annual revenue

$578.90M
CVAC annual revenue is $578.90 million

annual net income

$175.44M
CVAC annual net profit is $175.44 million

annual EBIT

$206.60M
CVAC annual earnings before interest & taxes is $206.60 million

Annual EPS

$0.78
CVAC annual earnings per share is $0.78

quarterly EBITDA:

-$52.75M-$7.45M(-16.44%)
March 31, 2025

Summary

  • As of today (September 8, 2025), CVAC quarterly EBITDA is -$52.75 million, with the most recent change of -$7.45 million (-16.44%) on March 31, 2025.
  • Over the past year, CVAC quarterly EBITDA has increased by +$25.52 million (+32.61%).
  • CVAC quarterly EBITDA is now -111.77% below its all-time high of $448.03 million, reached on September 30, 2024.

Performance

3-month change

-16.44%

1-year change

+32.61%

3-year change

-19.51%

5-year change

-99.28%

CVAC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

7.75%
CVAC quarterly EBITDA is higher than 7.75% of companies in Healthcare sector

Range

All-time high

$448.03M
CVAC quarterly EBITDA is currently -111.77% below its historical high of $448.03 million

3-year low

-$121.94M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CVAC previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Nov 11, 2025
CVAC next earnings announcement is scheduled for Nov 11, 2025

OtherCVACincome statement metrics

Quarterly revenue

$939.80K
CVAC quarterly revenue is $939.80 thousand

quarterly net income

-$54.82M
CVAC quarterly net profit is -$54.82 million

quarterly EBIT

-$57.83M
CVAC quarterly earnings before interest & taxes is -$57.83 million

Quarterly EPS

-$0.24
CVAC quarterly earnings per share is -$0.24

TTM EBITDA:

$276.28M+$25.52M(+10.18%)
March 31, 2025

Summary

  • As of today (September 8, 2025), CVAC TTM EBITDA is $276.28 million, with the most recent change of +$25.52 million (+10.18%) on March 31, 2025.
  • Over the past year, CVAC TTM EBITDA has increased by +$569.93 million (+194.08%).
  • CVAC TTM EBITDA is now at all-time high.

Performance

3-month change

+10.18%

1-year change

+194.08%

3-year change

+140.57%

5-year change

-

CVAC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

88.55%
CVAC TTM EBITDA is higher than 88.55% of companies in Healthcare sector

Range

All-time high

$276.28M
CVAC TTM EBITDA is currently at an all-time high

3-year low

-$785.46M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CVAC previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Nov 11, 2025
CVAC next earnings announcement is scheduled for Nov 11, 2025

OtherCVACincome statement metrics

TTM revenue

$574.49M
CVAC TTM revenue is $574.49 million

TTM net income

$203.50M
CVAC TTM net profit is $203.50 million

TTM EBIT

$252.33M
CVAC TTM earnings before interest & taxes is $252.33 million

TTM EPS

$0.91
CVAC TTM earnings per share is $0.91

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$226.96M
CVAC annual EBITDA is $226.96 million

annual net income

$175.44M
CVAC annual net profit is $175.44 million

annual interest expense

$0.00
CVAC annual interest expense is $0.00

annual income tax

$31.06M
CVAC annual income tax is $31.06 million

annual D&A

$20.36M
CVAC annual depreciation & amortization is $20.36 million

CVAC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+188.6%+32.6%+194.1%
3 y3 years+149.6%-19.5%+140.6%
5 y5 years+321.6%-99.3%-

CVAC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+149.6%-111.8%+56.7%at high+135.2%
5 y5-yearat high+149.6%-111.8%+91.7%at high+134.9%
alltimeall timeat high+149.6%-111.8%+91.7%at high+134.9%

CVAC EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$52.75M(+16.4%)
$276.28M(+10.2%)
Dec 2024
$226.96M(-188.6%)
-$45.30M(-110.1%)
$250.75M(+21.5%)
Sep 2024
-
$448.03M(-707.9%)
$206.30M(-170.1%)
Jun 2024
-
-$73.70M(-5.8%)
-$294.44M(+0.3%)
Mar 2024
-
-$78.27M(-12.8%)
-$293.65M(+6.7%)
Dec 2023
-$256.13M(+8.9%)
-$89.76M(+70.3%)
-$275.32M(-10.5%)
Sep 2023
-
-$52.71M(-27.7%)
-$307.50M(+2.1%)
Jun 2023
-
-$72.91M(+21.6%)
-$301.29M(+5.2%)
Mar 2023
-
-$59.94M(-50.8%)
-$286.28M(+5.8%)
Dec 2022
-$235.30M
-$121.94M(+162.2%)
-$270.47M(-65.6%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$46.50M(-19.7%)
-$785.46M(+6.3%)
Jun 2022
-
-$57.89M(+31.2%)
-$738.96M(+8.5%)
Mar 2022
-
-$44.14M(-93.1%)
-$681.06M(-14.1%)
Dec 2021
-$457.28M(+312.5%)
-$636.92M(+309.2%)
-$792.58M(+265.0%)
Mar 2021
-
-$155.66M(+153.2%)
-$217.15M(+146.9%)
Dec 2020
-$110.86M(+8.2%)
-$61.49M(+132.3%)
-$87.96M(+232.3%)
Mar 2020
-
-$26.47M(+9.1%)
-$26.47M(+9.1%)
Dec 2019
-$102.44M(+29.3%)
-
-
Mar 2019
-
-$24.27M
-$24.27M
Dec 2018
-$79.20M
-
-

FAQ

  • What is CureVac N.V. annual EBITDA?
  • What is the all time high annual EBITDA for CureVac N.V.?
  • What is CureVac N.V. annual EBITDA year-on-year change?
  • What is CureVac N.V. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CureVac N.V.?
  • What is CureVac N.V. quarterly EBITDA year-on-year change?
  • What is CureVac N.V. TTM EBITDA?
  • What is the all time high TTM EBITDA for CureVac N.V.?
  • What is CureVac N.V. TTM EBITDA year-on-year change?

What is CureVac N.V. annual EBITDA?

The current annual EBITDA of CVAC is $226.96M

What is the all time high annual EBITDA for CureVac N.V.?

CureVac N.V. all-time high annual EBITDA is $226.96M

What is CureVac N.V. annual EBITDA year-on-year change?

Over the past year, CVAC annual EBITDA has changed by +$483.08M (+188.61%)

What is CureVac N.V. quarterly EBITDA?

The current quarterly EBITDA of CVAC is -$52.75M

What is the all time high quarterly EBITDA for CureVac N.V.?

CureVac N.V. all-time high quarterly EBITDA is $448.03M

What is CureVac N.V. quarterly EBITDA year-on-year change?

Over the past year, CVAC quarterly EBITDA has changed by +$25.52M (+32.61%)

What is CureVac N.V. TTM EBITDA?

The current TTM EBITDA of CVAC is $276.28M

What is the all time high TTM EBITDA for CureVac N.V.?

CureVac N.V. all-time high TTM EBITDA is $276.28M

What is CureVac N.V. TTM EBITDA year-on-year change?

Over the past year, CVAC TTM EBITDA has changed by +$569.93M (+194.08%)
On this page